JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 65.50
+3.60 (5.82%)
Oct 15, 2025, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 209.70 billion as of October 15, 2025. Its market cap has increased by 159.27% in one year.
Market Cap
209.70B
Enterprise Value
156.14B
Revenue
71.34B
Ranking
n/a
PE Ratio
40.37
Stock Price
65.50
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 209.70B, a decrease of -39.04%. That is a compound annual growth rate of -9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 198.17B | 120.49% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
| Dec 8, 2020 | 343.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.71B |
| Hansoh Pharmaceutical Group Company | 209.83B |
| Innovent Biologics | 143.53B |
| WuXi Biologics | 140.85B |
| Sino Biopharmaceutical | 131.93B |
| Akeso | 111.46B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.05B |
| CSPC Pharmaceutical Group | 100.50B |